Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › TX › HOUSTON › RAJPUT, MUHAMMAD

RAJPUT, MUHAMMAD

NPI: 1558360248 · HOUSTON, TX 77090 · Pediatrics Physician · NPI assigned 07/15/2005

$3.31M
Total Medicaid Paid
131,076
Total Claims
112,100
Beneficiaries
58
Codes Billed
2019-10
First Month
2024-11
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2019 1,788 $42K
2020 15,709 $326K
2021 35,560 $759K
2022 33,397 $907K
2023 28,685 $834K
2024 15,937 $440K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 21,752 19,197 $818K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,347 4,184 $354K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,116 3,950 $352K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,937 2,765 $224K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2,206 2,118 $205K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 6,366 6,039 $185K
90460 Immunization administration through 18 years of age via any route, first or only component 16,143 8,321 $178K
S8301 Infection control supplies, not otherwise specified 15,483 12,867 $154K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,942 1,850 $151K
99429 3,988 3,839 $135K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,083 1,995 $111K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,057 1,021 $55K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,147 1,951 $53K
87634 947 882 $52K
99050 3,418 3,217 $48K
99381 627 548 $45K
96110 Developmental screening, with scoring and documentation, per standardized instrument 4,678 3,225 $38K
99383 354 347 $33K
90461 3,087 2,507 $22K
97803 5,845 5,541 $21K
99382 187 180 $17K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,206 1,107 $16K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 783 728 $11K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 677 320 $9K
99384 79 78 $8K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 381 349 $4K
T1013 Sign language or oral interpretive services, per 15 minutes 457 419 $2K
96160 918 882 $2K
96161 627 599 $1K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 24 23 $921.26
87807 69 66 $738.65
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 18 17 $557.57
A7016 Dome and mouthpiece, used with small volume ultrasonic nebulizer 114 98 $493.58
69210 13 12 $449.50
97802 71 69 $308.88
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 115 98 $228.11
99056 90 61 $188.65
90686 2,280 2,197 $39.20
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 5,718 5,380 $4.06
90697 1,383 1,309 $1.47
90677 483 448 $1.36
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 521 490 $0.63
90619 264 250 $0.22
90651 576 556 $0.15
90681 277 264 $0.07
90715 528 496 $0.04
90660 393 379 $0.01
90696 468 452 $0.01
90620 180 171 $0.01
J7612 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg 509 458 $0.00
90680 845 801 $0.00
90723 547 525 $0.00
90710 1,362 1,304 $0.00
90670 1,967 1,880 $0.00
90648 992 953 $0.00
90700 344 332 $0.00
90633 1,488 1,419 $0.00
90734 599 566 $0.00